Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BKK:IMH-R's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.915 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
InterMedical Care and Lab Hospital PCL (BKK:IMH-R) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
InterMedical Care and Lab Hospital PCL 5-Year Yield-on-Cost % Related Terms
BKK:IMH-R vs HCA, THC, EHC: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, InterMedical Care and Lab Hospital PCL's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InterMedical Care and Lab Hospital PCL 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, InterMedical Care and Lab Hospital PCL's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where InterMedical Care and Lab Hospital PCL's 5-Year Yield-on-Cost % falls into.
InterMedical Care and Lab Hospital PCL 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
InterMedical Care and Lab Hospital PCL (BKK:IMH-R) has a 5-Year Yield-on-Cost % of 0.00 as of Sep. 06, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on InterMedical Care and Lab Hospital PCL and its competitors. Over the past decade, InterMedical Care and Lab Hospital PCL's 5-Year Yield-on-Cost % has ranged from 1.20 to 8.33. According to the industry distribution chart, InterMedical Care and Lab Hospital PCL ranks #999999 out of 280 companies in the Healthcare Providers & Services industry.
Is InterMedical Care and Lab Hospital PCL's 5-Year Yield-on-Cost % too high?
InterMedical Care and Lab Hospital PCL's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 1.20 to a high of 8.33. Based on the distribution chart, InterMedical Care and Lab Hospital PCL ranks #999999 out of 280 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, InterMedical Care and Lab Hospital PCL has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does InterMedical Care and Lab Hospital PCL's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, InterMedical Care and Lab Hospital PCL ranks #999999 out of 280 companies for 5-Year Yield-on-Cost %. This places InterMedical Care and Lab Hospital PCL in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.92. Historically, InterMedical Care and Lab Hospital PCL's own 5-Year Yield-on-Cost % has ranged from 1.20 to 8.33 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.92, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on InterMedical Care and Lab Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InterMedical Care and Lab Hospital PCL's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InterMedical Care and Lab Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL (BKK:IMH-R) is currently considered Possible Value Trap. The stock's GF Value™ is ฿5.85, compared to a current price of ฿3.62 — trading 38.1% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. InterMedical Care and Lab Hospital PCL's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For InterMedical Care and Lab Hospital PCL (BKK:IMH-R), the current 5-Year Yield-on-Cost % is 0.00 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InterMedical Care and Lab Hospital PCL (BKK:IMH-R) Overvalued in 2026?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL stock appears to be undervalued.
The current stock price of ฿3.62 is trading 38.1% below its estimated GF Value™ of ฿5.85.
GuruFocus considers InterMedical Care and Lab Hospital PCL to be Possible Value Trap.
Key valuation signals for BKK:IMH-R:
5-Year Yield-on-Cost %: 0.00
GF Value™: ฿5.85 vs. price of ฿3.62 (38.1% below fair value)
No single metric tells the full story. See the BKK:IMH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InterMedical Care and Lab Hospital PCL is a company principally engaged in specialty medical hospitals, and occupational medicine. The business segments of the firm are Prachapat hospital, Occupational Medicine hospital and Environmental Analysis. Prachapat Hospital is engaged in rendering medical services to patients under government welfare schemes. Occupational Medicine Hospital is engaged in providing physical examination services. Majority of revenue is from Hospital Segment. Geographically, the company operates in Thailand.
70GF Score
Get the complete analysis for BKK:IMH-R
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:IMH-R has been successfully added to your 
